Challenging Cases in Immunotherapy Related Organ Toxicities, Gebunden

Klappentext

With the widespread adoption of checkpoint inhibitors as standard-of-care therapy for many cancers, the associated toxicities affecting multiple organ systems have become a significant limiting factor, particularly in select patient populations. Some organ-specific toxicities can be severe and life-threatening. Early recognition and prompt, effective management of these conditions are critical to improving patient care and ensuring the continued delivery of cancer therapy over the long term.

Designed as a companion volume to our first handbook Managing Immunotherapy-Related Organ Toxicitiespublished in 2022, this new book presents 65 unique and challenging cases involving toxicities across more than ten different organ systems. Each case includes a detailed clinical presentation, evaluation, treatment approach, and long-term patient outcome. The contributors are a group of leading experts from 14 centers worldwide, all of whom provide routine care for patients with complex toxicity conditions.

This is the first book of its kind, *Challenging Cases of Immunotherapy-Related Organ Toxicities,*highlighting the real-world challenges physicians encounter in oncology clinical practice.